AR051390A1 - Derivados de azetidina, pro - Google Patents
Derivados de azetidina, proInfo
- Publication number
- AR051390A1 AR051390A1 ARP050104296A ARP050104296A AR051390A1 AR 051390 A1 AR051390 A1 AR 051390A1 AR P050104296 A ARP050104296 A AR P050104296A AR P050104296 A ARP050104296 A AR P050104296A AR 051390 A1 AR051390 A1 AR 051390A1
- Authority
- AR
- Argentina
- Prior art keywords
- derivatives
- azetidina
- pro
- methylsulfonamide
- azetidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Procedimiento de preparacion e derivados de azetidina como el N-{1-[bis-(4-clorofenil)metil]azetidin-3-il}-N-quinol-6-il-metilsulfonamida y de su clorhidrato y del N-{1-[bis-(4-clorofenil)metil]azetidin-3-il}-N-(3,5-difluorofenil)- metilsulfonamida.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0410844A FR2876688B1 (fr) | 2004-10-14 | 2004-10-14 | Nouveau produit, procede et intermediaires de preparation de derives d'azetidine |
Publications (1)
Publication Number | Publication Date |
---|---|
AR051390A1 true AR051390A1 (es) | 2007-01-10 |
Family
ID=34954419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050104296A AR051390A1 (es) | 2004-10-14 | 2005-10-13 | Derivados de azetidina, pro |
Country Status (21)
Country | Link |
---|---|
US (1) | US7687493B2 (es) |
EP (1) | EP1805167A2 (es) |
JP (1) | JP2008516932A (es) |
KR (1) | KR20070063544A (es) |
CN (1) | CN101039931A (es) |
AR (1) | AR051390A1 (es) |
AU (1) | AU2005293454A1 (es) |
BR (1) | BRPI0516507A (es) |
CA (1) | CA2583992A1 (es) |
EA (1) | EA011408B1 (es) |
EC (1) | ECSP077332A (es) |
FR (1) | FR2876688B1 (es) |
IL (1) | IL181904A0 (es) |
MA (1) | MA29513B1 (es) |
MX (1) | MX2007003923A (es) |
NO (1) | NO20072192L (es) |
SG (1) | SG155193A1 (es) |
TN (1) | TNSN07097A1 (es) |
TW (1) | TW200630358A (es) |
WO (1) | WO2006040465A2 (es) |
ZA (1) | ZA200702528B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113045539B (zh) * | 2021-03-30 | 2021-12-07 | 苏州大学 | 2-(4,4-二氯-1-(8-喹啉基)-2-氮杂环丁基)羧酸酯衍生物的制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8709887D0 (en) * | 1987-04-27 | 1987-06-03 | Univ Alberta | Alkyl azodicarboxylates |
US5530134A (en) * | 1994-09-06 | 1996-06-25 | Synphar Laboratories Inc. | Synthesis of anabaseine, salts and derivatives thereof |
US6355631B1 (en) * | 2000-03-03 | 2002-03-12 | Aventis Pharma S.A. | Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation |
FR2805817B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation |
JP4101053B2 (ja) * | 2000-08-10 | 2008-06-11 | 田辺三菱製薬株式会社 | プロリン誘導体及びその医薬用途 |
US7825109B2 (en) * | 2003-08-29 | 2010-11-02 | Ono Pharmaceutical Co., Ltd. | Compound capable of binding S1P receptor and pharmaceutical use thereof |
-
2004
- 2004-10-14 FR FR0410844A patent/FR2876688B1/fr not_active Expired - Fee Related
-
2005
- 2005-10-10 BR BRPI0516507-5A patent/BRPI0516507A/pt not_active IP Right Cessation
- 2005-10-10 AU AU2005293454A patent/AU2005293454A1/en not_active Withdrawn
- 2005-10-10 EP EP05809232A patent/EP1805167A2/fr not_active Withdrawn
- 2005-10-10 KR KR1020077008461A patent/KR20070063544A/ko not_active Application Discontinuation
- 2005-10-10 JP JP2007536214A patent/JP2008516932A/ja active Pending
- 2005-10-10 SG SG200905236-6A patent/SG155193A1/en unknown
- 2005-10-10 MX MX2007003923A patent/MX2007003923A/es active IP Right Grant
- 2005-10-10 CN CNA2005800350837A patent/CN101039931A/zh active Pending
- 2005-10-10 CA CA002583992A patent/CA2583992A1/fr not_active Abandoned
- 2005-10-10 ZA ZA200702528A patent/ZA200702528B/xx unknown
- 2005-10-10 WO PCT/FR2005/002490 patent/WO2006040465A2/fr active Application Filing
- 2005-10-10 EA EA200700840A patent/EA011408B1/ru not_active IP Right Cessation
- 2005-10-13 TW TW094135607A patent/TW200630358A/zh unknown
- 2005-10-13 AR ARP050104296A patent/AR051390A1/es unknown
-
2007
- 2007-03-13 IL IL181904A patent/IL181904A0/en unknown
- 2007-03-16 TN TNP2007000097A patent/TNSN07097A1/fr unknown
- 2007-03-21 EC EC2007007332A patent/ECSP077332A/es unknown
- 2007-03-22 US US11/689,588 patent/US7687493B2/en not_active Expired - Fee Related
- 2007-04-27 NO NO20072192A patent/NO20072192L/no not_active Application Discontinuation
- 2007-05-11 MA MA29896A patent/MA29513B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
FR2876688A1 (fr) | 2006-04-21 |
KR20070063544A (ko) | 2007-06-19 |
BRPI0516507A (pt) | 2008-09-16 |
TNSN07097A1 (fr) | 2008-06-02 |
US20070270463A1 (en) | 2007-11-22 |
MA29513B1 (fr) | 2008-06-02 |
NO20072192L (no) | 2007-04-27 |
MX2007003923A (es) | 2007-06-07 |
TW200630358A (en) | 2006-09-01 |
EA011408B1 (ru) | 2009-02-27 |
WO2006040465A3 (fr) | 2006-08-10 |
ZA200702528B (en) | 2008-07-30 |
JP2008516932A (ja) | 2008-05-22 |
IL181904A0 (en) | 2007-07-04 |
ECSP077332A (es) | 2007-04-26 |
EP1805167A2 (fr) | 2007-07-11 |
FR2876688B1 (fr) | 2007-03-16 |
CN101039931A (zh) | 2007-09-19 |
US7687493B2 (en) | 2010-03-30 |
WO2006040465A2 (fr) | 2006-04-20 |
AU2005293454A1 (en) | 2006-04-20 |
EA200700840A1 (ru) | 2007-08-31 |
CA2583992A1 (fr) | 2006-04-20 |
SG155193A1 (en) | 2009-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20125666B (en) | HYDROXYMETHYL PYRROLIDINES AS β3 ADRENERGIC RECEPTOR AGONISTS | |
MX2007011023A (es) | 2-(4-oxo-4h-quinazolin-3-il) acetamidas y su uso como antagonistas de vasopresin v3. | |
EA200701114A1 (ru) | Азоловые производные с антимускариновой активностью | |
NZ596024A (en) | Indole compounds | |
ATE537170T1 (de) | Cgrp-rezeptorantagonisten | |
ATE469895T1 (de) | Cgrp-rezeptorantagonisten | |
CR8481A (es) | Derivados de triazol como antagonistas de la vasopresina | |
GEP20094785B (en) | Pyrrolopyrazoles, potent kinase inhibitors | |
ATE500250T1 (de) | Azetidinverbindungen als orexin-rezeptor- antagonisten | |
TW200738692A (en) | New substituted glycinamides, process for their manufacture and use thereof as medicaments | |
DE602005012634D1 (en) | Arylsulfonylnaphthalinderivate als 5ht2a-antagonisten | |
NO20081788L (no) | Cyklopropylaminer som modulatorer av histamin-H3-reseptoren | |
ATE411323T1 (de) | Cgrp-rezeptorantagonisten | |
TW200734313A (en) | Piperazines and piperidines as mGluR5 potentiators | |
PE20070490A1 (es) | Compuestos derivados de bencimidazol-2-ona sustituidos con piperidina como agonistas del receptor muscarinico m1 | |
MY146623A (en) | Substituted prolinamides, manufacturing, and the use thereof as medicaments | |
RS50624B (sr) | Monohidrohloridna so 1-[3-[3-(4-hlorofenil)propoksi]propil]piperidina | |
NO20084852L (no) | MGLUR5 modulatorer V | |
NO20084007L (no) | Spirokondenserte piperidiner som modulatorer av muskarinreseptorer | |
ATE444990T1 (de) | Spritzbare akustikmassen | |
EA201070689A1 (ru) | Композиция для личного ухода | |
DE602007013412D1 (de) | Therapeutische amide und entsprechende verbindungen | |
HRP20051005A2 (en) | Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives | |
ECSP088476A (es) | Combinación de productos activos fungicidas | |
TW200740769A (en) | Novel process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |